Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration

Intradialytic morbid events (IMEs) during haemodialysis (HD), including symptomatic hypotension, are related to ultrafiltration (UF)-induced hypovolaemia. Blood volume monitoring and automatic feedback control of the UF rate were developed to limit the extent of hypovolaemia during dialysis. The pre...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of nephrology Vol. 22; no. 2; p. 232
Main Authors:	Gabrielli, Danila, Krystal, Batya, Katzarski, Krassimir, Youssef, Maan, Hachache, Toufic, Lopot, Frantisek, Lasseur, Catherine, Gunne, Thomas, Draganov, Branimir, Wojke, Ralf, Gauly, Adelheid
Format:	Journal Article
Language:	English
Published:	Italy 01-03-2009
Subjects:	Aged Blood Volume - physiology Blood Volume Determination Cross-Over Studies Female Fluid Therapy - methods Follow-Up Studies Humans Hypertonic Solutions - administration & dosage Hypotension - etiology Hypotension - physiopathology Hypotension - prevention & control Hypotension, Orthostatic - etiology Hypotension, Orthostatic - physiopathology Hypotension, Orthostatic - prevention & control Hypovolemia - complications Hypovolemia - physiopathology Hypovolemia - therapy Infusions, Intravenous Isotonic Solutions - administration & dosage Male Prospective Studies Renal Dialysis - adverse effects Renal Dialysis - methods Time Factors Treatment Outcome
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Intradialytic morbid events (IMEs) during haemodialysis (HD), including symptomatic hypotension, are related to ultrafiltration (UF)-induced hypovolaemia. Blood volume monitoring and automatic feedback control of the UF rate were developed to limit the extent of hypovolaemia during dialysis. The present study investigated the effect of blood volume (BV)-controlled UF on the incidence of HD treatments with IMEs. This prospective randomised crossover study included hypotension-prone patients, characterised by occurrence of IMEs in at least 33% of HD treatments during a 6-week screening phase. These patients underwent 2 treatment phases, each lasting 6 weeks, in randomised order. Each patient served as their own control, treated with standard HD in one phase and with BV-controlled UF in the other phase. Thirty-four patients from 9 HD centres were enrolled; 26 could be included in the analysis population. In comparison with standard HD, BV-controlled UF reduced the percentage of HD sessions complicated by IME significantly from 40%+/-27% to 32%+/-25% (p=0.02). A lower frequency of HD sessions with IME could be observed in 46% of the patients. The frequency of treatments with symptomatic hypotension was reduced from 32%+/-23% in standard HD to 24%+/-21% with BV-controlled UF (p=0.04). Changes in blood pressure and heart rate from start to end of the HD session were not different between the 2 treatment modes. This crossover study showed improved intradialytic stability with BV-controlled UF, compared with standard HD.
ISSN:	1121-8428